2m 2m 2m 2m 2m 2m 2m
TEVOGEN BIO (TVGN)
NASDAQ
$9.00+$0.53 (+6.27%)
Price as of Jun 03, 2026 7:02 PM EDT- $33.1MMarket Cap
- -86.77%1-Year Change
- BiotechnologyIndustry
TEVOGEN BIO (TVGN)
$9.00+$0.53 (+6.27%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | -195,618 N/A | N/A N/A | 2.7M -44.74% | 4.9M N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | -195,618 N/A | 0 -100.00% | 2.7M -44.74% | 4.9M N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -11.1M -64.19% | -31.0M N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 190,573 +17.49% | 162,209 N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 26.1M -51.20% | 53.6M +2,255.55% | 2.3M +138.59% | 953,083 +425.34% | |
Operating Profit | -26.1M -51.20% | -53.6M +79,461.07% | -67,325 -101.53% | 4.4M +15,436.10% | |
Interest Income | N/A N/A | N/A N/A | 2.7M -44.75% | 4.9M +31,204.57% | |
Interest Expense | -195,618 +6.29% | -184,037 -28.12% | -256,031 N/A | N/A N/A | |
Interest Income and Expense and Net | -195,618 +6.29% | -184,037 -107.43% | 2.5M -49.92% | 4.9M +31,204.57% | |
Total Nonoperating Income and Expense | -195,618 -206.29% | 184,037 -91.66% | 2.2M -58.84% | 5.4M +3,411.67% | |
Income before Taxes | -26.8M +161.11% | -10.3M +15,159.85% | -67,325 -101.53% | 4.4M +15,436.10% | |
Income Taxes | 4,750 N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -26.8M +161.11% | -10.3M +15,159.85% | -67,325 -101.53% | 4.4M +15,436.10% | |
Net Income from Continuing Operations Applicable to Common | -26.8M +161.11% | -10.3M +15,159.85% | -67,325 -101.53% | 4.4M +15,436.10% | |
Basic EPS and Net Income | -8.08 +11,442.86% | -0.07 N/A | 0.00 -100.00% | 0.18 N/A | |
Diluted EPS and Net Income | -8.08 +11,442.86% | -0.07 N/A | 0.00 -100.00% | 0.18 N/A | |
Basic Weighted Average Shares | 3.3M -97.74% | 146.7M +290.77% | 37.5M -21.70% | 47.9M +149.89% | |
Diluted Weighted Average Shares | 3.3M -97.74% | 146.7M +290.77% | 37.5M -21.70% | 47.9M +149.89% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 552,372 -56.95% | 1.3M +14,421.73% | 8,835 -93.16% | 129,186 -62.51% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 552,372 -56.95% | 1.3M +14,421.73% | 8,835 -93.16% | 129,186 -62.51% | |
Total Current Assets | 1.5M -34.78% | 2.4M +563.48% | 355,836 +29.70% | 274,356 -65.32% | |
Accumulated Depreciation | 414,529 -2.54% | 425,327 N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 170,308 -42.55% | 296,442 N/A | N/A N/A | N/A N/A | |
Total Long-Term Assets | 1.1M +85.10% | 575,841 -98.17% | 31.4M -91.55% | 371.6M +1.35% | |
Total Assets | 4.4M +26.61% | 3.5M -79.68% | 17.0M -95.23% | 357.1M +1.21% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | 140,000 +600.00% | |
Total Short-Term Debt | 1.7M 0.00% | 1.7M +1.18% | 1.6M N/A | N/A N/A | |
Total Current Liabilities | 7.1M -21.83% | 9.0M +201.01% | 3.0M +757.21% | 350,454 +490.24% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 1.1M +19,271.12% | 5,796 -99.96% | 14.7M +0.15% | 14.7M -2.73% | |
Total Liabilities | 12.6M +24.49% | 10.1M -42.84% | 17.7M +17.77% | 15.1M -0.80% | |
Retained Earnings | -139.7M +23.17% | -113.4M +552.44% | -17.4M +17.54% | -14.8M +3.90% | |
Total Stockholders Equity | N/A N/A | N/A N/A | -17.4M +17.55% | -14.8M +3.91% | |
Total Shares Outstanding | 4.0M -97.74% | 178.0M +1,091.73% | 14.9M +526.74% | 2.4M -82.26% | |
Cash Flow | |||||
Cash from Operating Activities | -12.3M +2.75% | -12.0M +771.78% | -1.4M +538.99% | -215,395 -69.83% | |
Capital Expenditures | 64,439 N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -64,439 N/A | N/A N/A | 342.9M +197.45% | -351.9M 0.00% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 11.7M -4.64% | 12.2M +103.58% | -341.7M -196.80% | 353.0M 0.00% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | 13,363.04% N/A | N/A N/A | -2.46% -102.76% | 89.09% N/A | |
Return on Assets | -683.91% +582.30% | -100.24% +278,333.33% | -0.04% -102.90% | 1.24% N/A | |
Return on Equity | N/A N/A | N/A N/A | 0.42% +101.38% | -30.39% N/A | |
Revenue Growth | N/A N/A | N/A N/A | -44.74% N/A | N/A N/A | |
Current Ratio | 0.22 -16.58% | 0.26 +120.52% | 0.12 -84.88% | 0.78 N/A | |
Cash Ratio | 0.08 -44.96% | 0.14 +4,793.10% | 0.003 -99.21% | 0.37 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow